Nano-X Imaging Ltd at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Steve Halper with equity research at Cantor Fitzgerald. We're very happy to have with us today Ran Poliakine, who is the Founder and CEO of Nanox. My colleague and I -- Kyle Mikson, initiated coverage today of Nanox within the life science tools and diagnostics space. Our rating is overweight and a price target of $70. Nanox is a very exciting story with tremendous growth opportunity in front of us. Ran is going to go through the company's presentation. And if there's time at the end, we'll ask some questions. (Operator Instructions)
Ran, thank you so much for participating in our virtual health care conference, and I'll turn it over to you now.
Thank you very much, Steven, and good morning, everybody. I'm going to tell you the story of Nanox. So hang on, let me -- I have some technical challenges. Okay. Okay. So this slide that you can see on the screen actually is a snapshot of Nanox. Again, my name is Ran
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
